| 0.6 |
3.4 |
GO:2000661 |
positive regulation of interleukin-1-mediated signaling pathway(GO:2000661) |
| 0.5 |
0.5 |
GO:0006714 |
sesquiterpenoid metabolic process(GO:0006714) sesquiterpenoid catabolic process(GO:0016107) farnesol metabolic process(GO:0016487) farnesol catabolic process(GO:0016488) |
| 0.4 |
1.4 |
GO:0006788 |
heme oxidation(GO:0006788) |
| 0.3 |
2.0 |
GO:0006982 |
response to lipid hydroperoxide(GO:0006982) |
| 0.2 |
0.7 |
GO:0032289 |
central nervous system myelin formation(GO:0032289) |
| 0.2 |
1.4 |
GO:0009753 |
response to jasmonic acid(GO:0009753) cellular response to jasmonic acid stimulus(GO:0071395) |
| 0.2 |
0.5 |
GO:0043449 |
cellular alkene metabolic process(GO:0043449) |
| 0.1 |
0.6 |
GO:0090119 |
vesicle-mediated cholesterol transport(GO:0090119) |
| 0.1 |
0.4 |
GO:0061537 |
glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
| 0.1 |
0.7 |
GO:0002901 |
mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
| 0.1 |
0.4 |
GO:0008057 |
eye pigment granule organization(GO:0008057) |
| 0.1 |
0.6 |
GO:0018101 |
protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
| 0.1 |
0.6 |
GO:0097029 |
mature conventional dendritic cell differentiation(GO:0097029) |
| 0.1 |
0.4 |
GO:0043438 |
acetoacetic acid metabolic process(GO:0043438) |
| 0.1 |
0.5 |
GO:0000270 |
peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
| 0.1 |
1.2 |
GO:0031580 |
membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
| 0.1 |
0.8 |
GO:0035879 |
plasma membrane lactate transport(GO:0035879) |
| 0.1 |
0.7 |
GO:0007500 |
mesodermal cell fate determination(GO:0007500) |
| 0.1 |
0.9 |
GO:1902998 |
macrophage proliferation(GO:0061517) microglial cell proliferation(GO:0061518) regulation of neuronal signal transduction(GO:1902847) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
| 0.1 |
1.9 |
GO:2000194 |
regulation of female gonad development(GO:2000194) |
| 0.1 |
0.3 |
GO:0007037 |
vacuolar phosphate transport(GO:0007037) positive regulation of mitotic cell cycle DNA replication(GO:1903465) positive regulation of parathyroid hormone secretion(GO:2000830) |
| 0.1 |
0.3 |
GO:0021538 |
epithalamus development(GO:0021538) habenula development(GO:0021986) general adaptation syndrome(GO:0051866) |
| 0.1 |
0.4 |
GO:0035803 |
egg coat formation(GO:0035803) |
| 0.1 |
0.5 |
GO:0033274 |
response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
| 0.1 |
0.3 |
GO:1902996 |
regulation of neurofibrillary tangle assembly(GO:1902996) |
| 0.1 |
0.4 |
GO:0010652 |
regulation of cell communication by chemical coupling(GO:0010645) positive regulation of cell communication by chemical coupling(GO:0010652) |
| 0.1 |
0.1 |
GO:1901295 |
regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:1901295) regulation of canonical Wnt signaling pathway involved in heart development(GO:1905066) |
| 0.1 |
0.8 |
GO:0050653 |
chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0050653) |
| 0.1 |
0.6 |
GO:1903281 |
protein transport into plasma membrane raft(GO:0044861) positive regulation of calcium:sodium antiporter activity(GO:1903281) positive regulation of potassium ion import(GO:1903288) |
| 0.1 |
1.8 |
GO:0019800 |
peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.1 |
0.6 |
GO:1902896 |
terminal web assembly(GO:1902896) |
| 0.1 |
0.4 |
GO:1903207 |
neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
| 0.1 |
0.3 |
GO:0042361 |
menaquinone catabolic process(GO:0042361) vitamin K catabolic process(GO:0042377) |
| 0.1 |
0.7 |
GO:0002074 |
extraocular skeletal muscle development(GO:0002074) |
| 0.1 |
0.4 |
GO:0071934 |
thiamine transmembrane transport(GO:0071934) |
| 0.1 |
0.4 |
GO:0036343 |
psychomotor behavior(GO:0036343) |
| 0.1 |
0.1 |
GO:0007189 |
adenylate cyclase-activating G-protein coupled receptor signaling pathway(GO:0007189) |
| 0.1 |
0.3 |
GO:0045014 |
carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
| 0.1 |
1.1 |
GO:1904352 |
positive regulation of protein catabolic process in the vacuole(GO:1904352) |
| 0.1 |
0.6 |
GO:0086048 |
membrane depolarization during bundle of His cell action potential(GO:0086048) |
| 0.1 |
0.2 |
GO:0038169 |
somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
| 0.1 |
0.2 |
GO:0070446 |
cellular response to caloric restriction(GO:0061433) negative regulation of oligodendrocyte progenitor proliferation(GO:0070446) |
| 0.1 |
0.4 |
GO:1900748 |
positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 0.1 |
0.1 |
GO:0018205 |
peptidyl-lysine modification(GO:0018205) |
| 0.1 |
0.2 |
GO:0019442 |
tryptophan catabolic process to acetyl-CoA(GO:0019442) |
| 0.1 |
0.2 |
GO:1902310 |
positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
| 0.1 |
0.2 |
GO:0002904 |
positive regulation of B cell apoptotic process(GO:0002904) |
| 0.1 |
0.3 |
GO:0072709 |
cellular response to sorbitol(GO:0072709) |
| 0.1 |
0.2 |
GO:1901842 |
negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
| 0.1 |
0.6 |
GO:0006686 |
sphingomyelin biosynthetic process(GO:0006686) |
| 0.1 |
0.2 |
GO:0072011 |
glomerular endothelium development(GO:0072011) |
| 0.1 |
0.1 |
GO:1900020 |
regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
| 0.1 |
0.3 |
GO:0035995 |
skeletal muscle myosin thick filament assembly(GO:0030241) detection of muscle stretch(GO:0035995) |
| 0.1 |
0.1 |
GO:0021539 |
subthalamus development(GO:0021539) |
| 0.1 |
0.8 |
GO:0015884 |
folic acid transport(GO:0015884) |
| 0.1 |
0.3 |
GO:1903588 |
negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
| 0.1 |
0.4 |
GO:0060672 |
epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 0.1 |
0.2 |
GO:0006617 |
SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition(GO:0006617) |
| 0.1 |
0.4 |
GO:0030200 |
heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 0.1 |
0.3 |
GO:0015891 |
iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
| 0.1 |
0.8 |
GO:0042501 |
serine phosphorylation of STAT protein(GO:0042501) |
| 0.1 |
0.3 |
GO:0042357 |
thiamine diphosphate metabolic process(GO:0042357) |
| 0.1 |
0.2 |
GO:1904504 |
regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
| 0.1 |
0.2 |
GO:0042264 |
peptidyl-aspartic acid hydroxylation(GO:0042264) |
| 0.1 |
1.0 |
GO:0046520 |
sphingoid biosynthetic process(GO:0046520) |
| 0.1 |
0.8 |
GO:0002191 |
cap-dependent translational initiation(GO:0002191) |
| 0.1 |
0.2 |
GO:0051970 |
negative regulation of transmission of nerve impulse(GO:0051970) |
| 0.1 |
0.4 |
GO:0035881 |
amacrine cell differentiation(GO:0035881) |
| 0.1 |
0.2 |
GO:0042704 |
uterine wall breakdown(GO:0042704) |
| 0.1 |
0.1 |
GO:0031587 |
positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
| 0.0 |
0.0 |
GO:0010728 |
regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
| 0.0 |
0.2 |
GO:1904049 |
negative regulation of spontaneous neurotransmitter secretion(GO:1904049) |
| 0.0 |
0.3 |
GO:2000252 |
negative regulation of feeding behavior(GO:2000252) |
| 0.0 |
0.2 |
GO:0048806 |
genitalia development(GO:0048806) |
| 0.0 |
0.1 |
GO:0002372 |
myeloid dendritic cell cytokine production(GO:0002372) |
| 0.0 |
0.2 |
GO:0002426 |
immunoglobulin production in mucosal tissue(GO:0002426) |
| 0.0 |
0.1 |
GO:0030816 |
positive regulation of cAMP metabolic process(GO:0030816) |
| 0.0 |
0.2 |
GO:0042231 |
interleukin-13 biosynthetic process(GO:0042231) |
| 0.0 |
0.3 |
GO:0010751 |
negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
| 0.0 |
0.1 |
GO:0016561 |
protein import into peroxisome matrix, translocation(GO:0016561) |
| 0.0 |
0.2 |
GO:0072137 |
condensed mesenchymal cell proliferation(GO:0072137) |
| 0.0 |
0.3 |
GO:0001757 |
somite specification(GO:0001757) |
| 0.0 |
0.3 |
GO:1904674 |
positive regulation of somatic stem cell population maintenance(GO:1904674) |
| 0.0 |
0.4 |
GO:1904327 |
protein localization to cytosolic proteasome complex(GO:1904327) protein localization to cytosolic proteasome complex involved in ERAD pathway(GO:1904379) |
| 0.0 |
0.4 |
GO:0001867 |
complement activation, lectin pathway(GO:0001867) |
| 0.0 |
0.2 |
GO:0021780 |
oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
| 0.0 |
0.4 |
GO:0045218 |
zonula adherens maintenance(GO:0045218) |
| 0.0 |
0.2 |
GO:0061289 |
cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) |
| 0.0 |
0.3 |
GO:0008295 |
spermidine biosynthetic process(GO:0008295) |
| 0.0 |
0.3 |
GO:0043353 |
enucleate erythrocyte differentiation(GO:0043353) |
| 0.0 |
0.1 |
GO:0033319 |
UDP-D-xylose metabolic process(GO:0033319) UDP-D-xylose biosynthetic process(GO:0033320) |
| 0.0 |
0.2 |
GO:1904098 |
regulation of protein O-linked glycosylation(GO:1904098) positive regulation of protein O-linked glycosylation(GO:1904100) |
| 0.0 |
0.3 |
GO:0032439 |
endosome localization(GO:0032439) |
| 0.0 |
0.5 |
GO:0043152 |
induction of bacterial agglutination(GO:0043152) |
| 0.0 |
0.3 |
GO:0051005 |
negative regulation of lipoprotein lipase activity(GO:0051005) |
| 0.0 |
0.1 |
GO:0043311 |
positive regulation of eosinophil degranulation(GO:0043311) positive regulation of eosinophil activation(GO:1902568) |
| 0.0 |
0.2 |
GO:0035455 |
response to interferon-alpha(GO:0035455) |
| 0.0 |
0.2 |
GO:0060574 |
intestinal epithelial cell maturation(GO:0060574) |
| 0.0 |
0.1 |
GO:0035482 |
gastric motility(GO:0035482) gastric emptying(GO:0035483) positive regulation of growth rate(GO:0040010) negative regulation of circadian sleep/wake cycle, REM sleep(GO:0042322) regulation of gastric mucosal blood circulation(GO:1904344) positive regulation of gastric mucosal blood circulation(GO:1904346) gastric mucosal blood circulation(GO:1990768) |
| 0.0 |
0.1 |
GO:0002541 |
activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
| 0.0 |
0.2 |
GO:0030538 |
embryonic genitalia morphogenesis(GO:0030538) |
| 0.0 |
0.2 |
GO:0097327 |
response to antineoplastic agent(GO:0097327) |
| 0.0 |
0.1 |
GO:0006043 |
glucosamine catabolic process(GO:0006043) |
| 0.0 |
0.3 |
GO:0006740 |
NADPH regeneration(GO:0006740) |
| 0.0 |
0.6 |
GO:0060315 |
negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
| 0.0 |
0.3 |
GO:0022605 |
oogenesis stage(GO:0022605) |
| 0.0 |
0.1 |
GO:1905205 |
positive regulation of connective tissue replacement(GO:1905205) |
| 0.0 |
0.8 |
GO:1903504 |
regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
| 0.0 |
0.3 |
GO:1990034 |
calcium ion export(GO:1901660) calcium ion export from cell(GO:1990034) |
| 0.0 |
0.1 |
GO:1904647 |
response to rotenone(GO:1904647) |
| 0.0 |
0.4 |
GO:0035457 |
cellular response to interferon-alpha(GO:0035457) |
| 0.0 |
0.5 |
GO:0060120 |
auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
| 0.0 |
0.1 |
GO:0042320 |
regulation of circadian sleep/wake cycle, REM sleep(GO:0042320) |
| 0.0 |
0.4 |
GO:0015712 |
hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.0 |
0.1 |
GO:0090032 |
negative regulation of glucocorticoid metabolic process(GO:0031944) negative regulation of glucocorticoid biosynthetic process(GO:0031947) negative regulation of hormone metabolic process(GO:0032351) negative regulation of hormone biosynthetic process(GO:0032353) negative regulation of steroid hormone biosynthetic process(GO:0090032) |
| 0.0 |
0.2 |
GO:0016139 |
glycoside catabolic process(GO:0016139) |
| 0.0 |
0.2 |
GO:0050957 |
equilibrioception(GO:0050957) |
| 0.0 |
0.1 |
GO:2000097 |
regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
| 0.0 |
0.2 |
GO:0072092 |
ureteric bud invasion(GO:0072092) |
| 0.0 |
0.3 |
GO:0042905 |
9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
| 0.0 |
0.1 |
GO:0015772 |
disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.0 |
0.1 |
GO:0010760 |
negative regulation of macrophage chemotaxis(GO:0010760) |
| 0.0 |
0.5 |
GO:0019371 |
cyclooxygenase pathway(GO:0019371) |
| 0.0 |
0.1 |
GO:0031990 |
mRNA export from nucleus in response to heat stress(GO:0031990) |
| 0.0 |
0.4 |
GO:0035562 |
negative regulation of chromatin binding(GO:0035562) |
| 0.0 |
0.3 |
GO:1902430 |
negative regulation of beta-amyloid formation(GO:1902430) |
| 0.0 |
0.1 |
GO:0060981 |
cell migration involved in coronary angiogenesis(GO:0060981) |
| 0.0 |
0.1 |
GO:0031394 |
positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
| 0.0 |
0.1 |
GO:0033499 |
galactose catabolic process via UDP-galactose(GO:0033499) |
| 0.0 |
0.5 |
GO:0006957 |
complement activation, alternative pathway(GO:0006957) |
| 0.0 |
0.2 |
GO:0014057 |
positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
| 0.0 |
0.1 |
GO:0007181 |
transforming growth factor beta receptor complex assembly(GO:0007181) |
| 0.0 |
0.2 |
GO:0010816 |
substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
| 0.0 |
0.1 |
GO:0007509 |
mesoderm migration involved in gastrulation(GO:0007509) |
| 0.0 |
0.1 |
GO:0019243 |
methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
| 0.0 |
0.1 |
GO:0050712 |
negative regulation of interleukin-1 alpha production(GO:0032690) negative regulation of interleukin-1 alpha secretion(GO:0050712) |
| 0.0 |
0.2 |
GO:2000670 |
positive regulation of dendritic cell apoptotic process(GO:2000670) |
| 0.0 |
0.1 |
GO:0001514 |
selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.0 |
0.1 |
GO:0007525 |
somatic muscle development(GO:0007525) |
| 0.0 |
0.2 |
GO:0001575 |
globoside metabolic process(GO:0001575) |
| 0.0 |
0.3 |
GO:0034058 |
endosomal vesicle fusion(GO:0034058) |
| 0.0 |
0.1 |
GO:0006127 |
glycerophosphate shuttle(GO:0006127) |
| 0.0 |
0.4 |
GO:0042574 |
retinal metabolic process(GO:0042574) |
| 0.0 |
0.2 |
GO:0019236 |
response to pheromone(GO:0019236) |
| 0.0 |
0.1 |
GO:0009447 |
putrescine catabolic process(GO:0009447) |
| 0.0 |
0.1 |
GO:0050764 |
regulation of phagocytosis(GO:0050764) |
| 0.0 |
0.0 |
GO:0030573 |
bile acid catabolic process(GO:0030573) |
| 0.0 |
0.1 |
GO:0030311 |
poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
| 0.0 |
0.3 |
GO:0034127 |
regulation of MyD88-independent toll-like receptor signaling pathway(GO:0034127) |
| 0.0 |
0.3 |
GO:0006689 |
ganglioside catabolic process(GO:0006689) |
| 0.0 |
0.1 |
GO:0097009 |
energy homeostasis(GO:0097009) |
| 0.0 |
0.1 |
GO:0003409 |
optic cup structural organization(GO:0003409) |
| 0.0 |
0.2 |
GO:0032534 |
regulation of microvillus assembly(GO:0032534) |
| 0.0 |
0.1 |
GO:0035574 |
histone H4-K20 demethylation(GO:0035574) |
| 0.0 |
0.4 |
GO:0070050 |
neuron cellular homeostasis(GO:0070050) |
| 0.0 |
0.1 |
GO:0036289 |
peptidyl-serine autophosphorylation(GO:0036289) |
| 0.0 |
0.1 |
GO:0046909 |
intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
| 0.0 |
0.1 |
GO:0072752 |
cellular response to rapamycin(GO:0072752) |
| 0.0 |
0.2 |
GO:0002154 |
thyroid hormone mediated signaling pathway(GO:0002154) regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
| 0.0 |
3.0 |
GO:0070268 |
cornification(GO:0070268) |
| 0.0 |
0.1 |
GO:0034553 |
respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
| 0.0 |
0.1 |
GO:0006574 |
valine catabolic process(GO:0006574) |
| 0.0 |
0.3 |
GO:0005513 |
detection of calcium ion(GO:0005513) |
| 0.0 |
0.1 |
GO:0060010 |
Sertoli cell fate commitment(GO:0060010) |
| 0.0 |
0.2 |
GO:1903788 |
mycotoxin catabolic process(GO:0043387) aflatoxin catabolic process(GO:0046223) organic heteropentacyclic compound catabolic process(GO:1901377) regulation of glutathione biosynthetic process(GO:1903786) positive regulation of glutathione biosynthetic process(GO:1903788) |
| 0.0 |
0.1 |
GO:0016267 |
O-glycan processing, core 1(GO:0016267) |
| 0.0 |
0.1 |
GO:0043652 |
engulfment of apoptotic cell(GO:0043652) |
| 0.0 |
0.1 |
GO:0061394 |
regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance(GO:0061394) |
| 0.0 |
0.0 |
GO:1900041 |
negative regulation of interleukin-2 secretion(GO:1900041) |
| 0.0 |
0.2 |
GO:2000795 |
negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
| 0.0 |
0.1 |
GO:0032661 |
regulation of interleukin-18 production(GO:0032661) |
| 0.0 |
0.4 |
GO:0015871 |
choline transport(GO:0015871) |
| 0.0 |
0.0 |
GO:0098917 |
retrograde trans-synaptic signaling(GO:0098917) |
| 0.0 |
0.5 |
GO:0034587 |
piRNA metabolic process(GO:0034587) |
| 0.0 |
0.2 |
GO:1904637 |
response to ionomycin(GO:1904636) cellular response to ionomycin(GO:1904637) |
| 0.0 |
0.2 |
GO:2001256 |
regulation of store-operated calcium entry(GO:2001256) |
| 0.0 |
0.1 |
GO:0009443 |
pyridoxal 5'-phosphate salvage(GO:0009443) |
| 0.0 |
0.1 |
GO:0032570 |
response to progesterone(GO:0032570) |
| 0.0 |
0.1 |
GO:0002725 |
negative regulation of T cell cytokine production(GO:0002725) |
| 0.0 |
0.2 |
GO:2001206 |
positive regulation of osteoclast development(GO:2001206) |
| 0.0 |
0.1 |
GO:0070445 |
oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
| 0.0 |
0.3 |
GO:0002227 |
innate immune response in mucosa(GO:0002227) |
| 0.0 |
0.2 |
GO:0009134 |
nucleoside diphosphate catabolic process(GO:0009134) |
| 0.0 |
0.2 |
GO:1903944 |
regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
| 0.0 |
0.1 |
GO:0019858 |
cytosine metabolic process(GO:0019858) |
| 0.0 |
0.7 |
GO:0032332 |
positive regulation of chondrocyte differentiation(GO:0032332) |
| 0.0 |
0.3 |
GO:0035372 |
protein localization to microtubule(GO:0035372) |
| 0.0 |
0.1 |
GO:0016094 |
polyprenol biosynthetic process(GO:0016094) |
| 0.0 |
0.1 |
GO:1990258 |
box C/D snoRNA 3'-end processing(GO:0000494) box C/D snoRNA metabolic process(GO:0033967) box C/D snoRNA processing(GO:0034963) histone glutamine methylation(GO:1990258) |
| 0.0 |
0.2 |
GO:0030043 |
actin filament fragmentation(GO:0030043) |
| 0.0 |
0.1 |
GO:0006432 |
phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.0 |
0.1 |
GO:0014816 |
skeletal muscle satellite cell differentiation(GO:0014816) |
| 0.0 |
0.1 |
GO:0019918 |
peptidyl-arginine methylation, to symmetrical-dimethyl arginine(GO:0019918) |
| 0.0 |
0.1 |
GO:0010801 |
negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
| 0.0 |
0.1 |
GO:0035694 |
mitochondrial protein catabolic process(GO:0035694) |
| 0.0 |
0.1 |
GO:0045360 |
regulation of interleukin-1 biosynthetic process(GO:0045360) positive regulation of interleukin-1 biosynthetic process(GO:0045362) |
| 0.0 |
0.1 |
GO:0070673 |
response to interleukin-18(GO:0070673) |
| 0.0 |
0.1 |
GO:0006616 |
SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
| 0.0 |
0.4 |
GO:0042572 |
retinol metabolic process(GO:0042572) |
| 0.0 |
0.1 |
GO:0048015 |
phosphatidylinositol-mediated signaling(GO:0048015) inositol lipid-mediated signaling(GO:0048017) |
| 0.0 |
0.1 |
GO:0046364 |
hexose biosynthetic process(GO:0019319) monosaccharide biosynthetic process(GO:0046364) |
| 0.0 |
0.1 |
GO:0051414 |
response to cortisol(GO:0051414) |
| 0.0 |
0.1 |
GO:0031179 |
peptide amidation(GO:0001519) protein amidation(GO:0018032) peptide modification(GO:0031179) |
| 0.0 |
0.0 |
GO:0014052 |
regulation of gamma-aminobutyric acid secretion(GO:0014052) |
| 0.0 |
0.1 |
GO:1901079 |
dense core granule biogenesis(GO:0061110) positive regulation of relaxation of muscle(GO:1901079) positive regulation of relaxation of cardiac muscle(GO:1901899) regulation of dense core granule biogenesis(GO:2000705) |
| 0.0 |
0.1 |
GO:1904717 |
excitatory chemical synaptic transmission(GO:0098976) regulation of AMPA glutamate receptor clustering(GO:1904717) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
| 0.0 |
0.1 |
GO:0060481 |
lobar bronchus epithelium development(GO:0060481) |
| 0.0 |
0.1 |
GO:0061591 |
calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylserine scrambling(GO:0061589) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
| 0.0 |
0.1 |
GO:0032487 |
regulation of Rap protein signal transduction(GO:0032487) |
| 0.0 |
0.1 |
GO:1901503 |
ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
| 0.0 |
0.1 |
GO:0045226 |
hyaluranon cable assembly(GO:0036118) extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
| 0.0 |
0.1 |
GO:1900063 |
regulation of peroxisome organization(GO:1900063) |
| 0.0 |
0.0 |
GO:0090024 |
negative regulation of granulocyte chemotaxis(GO:0071623) negative regulation of neutrophil chemotaxis(GO:0090024) negative regulation of neutrophil migration(GO:1902623) |
| 0.0 |
0.2 |
GO:0007351 |
tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
| 0.0 |
0.1 |
GO:0015015 |
heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.0 |
1.4 |
GO:1900047 |
negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
| 0.0 |
0.4 |
GO:1901741 |
positive regulation of myoblast fusion(GO:1901741) |
| 0.0 |
0.1 |
GO:0033594 |
response to hydroxyisoflavone(GO:0033594) |
| 0.0 |
0.1 |
GO:0006390 |
transcription from mitochondrial promoter(GO:0006390) |
| 0.0 |
0.1 |
GO:0070901 |
mitochondrial tRNA methylation(GO:0070901) |
| 0.0 |
0.1 |
GO:1903644 |
regulation of chaperone-mediated protein folding(GO:1903644) |
| 0.0 |
0.2 |
GO:0023041 |
neuronal signal transduction(GO:0023041) |
| 0.0 |
0.6 |
GO:0060325 |
face morphogenesis(GO:0060325) |
| 0.0 |
0.4 |
GO:0070886 |
positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
| 0.0 |
0.1 |
GO:0018343 |
protein farnesylation(GO:0018343) |
| 0.0 |
0.5 |
GO:0016338 |
calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.0 |
0.0 |
GO:0010637 |
negative regulation of mitochondrial fusion(GO:0010637) |
| 0.0 |
0.1 |
GO:1905232 |
cellular response to L-glutamate(GO:1905232) |
| 0.0 |
0.1 |
GO:0030643 |
cellular phosphate ion homeostasis(GO:0030643) cellular divalent inorganic anion homeostasis(GO:0072501) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 0.0 |
0.1 |
GO:0019417 |
sulfur oxidation(GO:0019417) |
| 0.0 |
0.1 |
GO:1901299 |
negative regulation of hydrogen peroxide-mediated programmed cell death(GO:1901299) |
| 0.0 |
0.2 |
GO:0033601 |
positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
| 0.0 |
1.2 |
GO:0006081 |
cellular aldehyde metabolic process(GO:0006081) |
| 0.0 |
0.4 |
GO:0089711 |
L-glutamate transmembrane transport(GO:0089711) |
| 0.0 |
0.2 |
GO:1904262 |
negative regulation of TORC1 signaling(GO:1904262) |
| 0.0 |
1.1 |
GO:0007218 |
neuropeptide signaling pathway(GO:0007218) |
| 0.0 |
0.1 |
GO:0070537 |
histone H2A K63-linked deubiquitination(GO:0070537) |
| 0.0 |
0.0 |
GO:0043504 |
mitochondrial DNA repair(GO:0043504) |
| 0.0 |
0.2 |
GO:0010727 |
negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
| 0.0 |
0.2 |
GO:0090385 |
phagosome-lysosome fusion(GO:0090385) |
| 0.0 |
0.1 |
GO:0070173 |
regulation of enamel mineralization(GO:0070173) |
| 0.0 |
0.3 |
GO:0007084 |
mitotic nuclear envelope reassembly(GO:0007084) |
| 0.0 |
0.2 |
GO:0001837 |
epithelial to mesenchymal transition(GO:0001837) |
| 0.0 |
1.2 |
GO:0030574 |
collagen catabolic process(GO:0030574) |
| 0.0 |
0.0 |
GO:0060474 |
positive regulation of sperm motility involved in capacitation(GO:0060474) |
| 0.0 |
0.1 |
GO:1901341 |
activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
| 0.0 |
0.0 |
GO:0051466 |
positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
| 0.0 |
0.3 |
GO:0043517 |
positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
| 0.0 |
0.2 |
GO:0035331 |
negative regulation of hippo signaling(GO:0035331) |
| 0.0 |
0.1 |
GO:0018344 |
protein geranylgeranylation(GO:0018344) |
| 0.0 |
0.4 |
GO:0071174 |
mitotic spindle checkpoint(GO:0071174) |
| 0.0 |
0.1 |
GO:0032252 |
secretory granule localization(GO:0032252) |
| 0.0 |
1.5 |
GO:0071357 |
type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
| 0.0 |
0.1 |
GO:0006990 |
positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
| 0.0 |
0.1 |
GO:0048386 |
positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.0 |
0.1 |
GO:0071596 |
ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 0.0 |
0.1 |
GO:0010898 |
positive regulation of triglyceride catabolic process(GO:0010898) |
| 0.0 |
0.8 |
GO:0080171 |
lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
| 0.0 |
0.6 |
GO:0001523 |
retinoid metabolic process(GO:0001523) |
| 0.0 |
0.0 |
GO:0090080 |
positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
| 0.0 |
0.1 |
GO:1901978 |
positive regulation of cell cycle checkpoint(GO:1901978) |
| 0.0 |
0.0 |
GO:0070374 |
positive regulation of ERK1 and ERK2 cascade(GO:0070374) |
| 0.0 |
0.2 |
GO:0010603 |
regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
| 0.0 |
0.1 |
GO:0010890 |
positive regulation of sequestering of triglyceride(GO:0010890) |
| 0.0 |
1.0 |
GO:0048791 |
calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
| 0.0 |
0.0 |
GO:0045897 |
positive regulation of transcription during mitosis(GO:0045897) |
| 0.0 |
0.3 |
GO:0045332 |
phospholipid translocation(GO:0045332) |
| 0.0 |
0.2 |
GO:1900103 |
positive regulation of endoplasmic reticulum unfolded protein response(GO:1900103) |
| 0.0 |
0.0 |
GO:0046813 |
receptor-mediated virion attachment to host cell(GO:0046813) |
| 0.0 |
1.3 |
GO:0007422 |
peripheral nervous system development(GO:0007422) |
| 0.0 |
0.1 |
GO:0046092 |
deoxycytidine metabolic process(GO:0046092) |
| 0.0 |
0.1 |
GO:0045779 |
negative regulation of bone resorption(GO:0045779) |
| 0.0 |
0.0 |
GO:2001293 |
malonyl-CoA metabolic process(GO:2001293) |
| 0.0 |
0.0 |
GO:0034343 |
type III interferon production(GO:0034343) regulation of type III interferon production(GO:0034344) |
| 0.0 |
0.3 |
GO:0002576 |
platelet degranulation(GO:0002576) |
| 0.0 |
0.0 |
GO:0061034 |
olfactory bulb mitral cell layer development(GO:0061034) |
| 0.0 |
0.1 |
GO:0002860 |
positive regulation of natural killer cell mediated immune response to tumor cell(GO:0002857) positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002860) |
| 0.0 |
0.2 |
GO:0010002 |
cardioblast differentiation(GO:0010002) |
| 0.0 |
0.2 |
GO:0022401 |
desensitization of G-protein coupled receptor protein signaling pathway(GO:0002029) negative adaptation of signaling pathway(GO:0022401) |
| 0.0 |
0.2 |
GO:0099500 |
synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
| 0.0 |
0.1 |
GO:2001300 |
lipoxin metabolic process(GO:2001300) |
| 0.0 |
0.1 |
GO:0035610 |
protein side chain deglutamylation(GO:0035610) |
| 0.0 |
0.1 |
GO:0045741 |
positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
| 0.0 |
0.1 |
GO:0097084 |
vascular smooth muscle cell development(GO:0097084) |
| 0.0 |
0.2 |
GO:2000114 |
regulation of establishment of cell polarity(GO:2000114) |
| 0.0 |
0.1 |
GO:0021681 |
cerebellar granular layer development(GO:0021681) |
| 0.0 |
0.0 |
GO:0002803 |
positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) antimicrobial peptide production(GO:0002775) antibacterial peptide production(GO:0002778) regulation of antimicrobial peptide production(GO:0002784) regulation of antibacterial peptide production(GO:0002786) positive regulation of antibacterial peptide production(GO:0002803) |
| 0.0 |
0.5 |
GO:0006654 |
phosphatidic acid biosynthetic process(GO:0006654) |
| 0.0 |
0.1 |
GO:0060159 |
regulation of dopamine receptor signaling pathway(GO:0060159) |
| 0.0 |
0.1 |
GO:0090073 |
positive regulation of protein homodimerization activity(GO:0090073) |
